Ingrid A. Schrijver

824 citations
9 papers · 642 indexed · h-index 8

Ingrid A. Schrijver

9 papers receiving 628 citations

Peers

Ingrid A. Schrijver
Comparison fields: 5 of 83
  • Immunology 333
  • Microbiology 81
  • Biological Psychiatry 22
  • Rheumatology 110
  • Infectious Diseases 62
Replace Panayiotis Victoratos with:
Panayiotis Victoratos Greece
Michelle Duncan United States
Pragnesh Mistry United States
Natália Jaeger United States
Yuji Motoi Japan
Zhixin Song China
Eduardo Hernández-Cuellar Mexico
Amaya I. Wolf United States
Andrea P. Martin United States
Ingrid A. Schrijver relative to Panayiotis Victoratos Greece Panayiotis Victoratos's profile →
Citations per field
00.5×4.3×
Panayiotis Victoratos · 1×
Citations per year

Countries citing papers authored by Ingrid A. Schrijver

Since Specialization
Citations

This map shows the geographic impact of Ingrid A. Schrijver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid A. Schrijver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid A. Schrijver more than expected).

Fields of papers citing papers by Ingrid A. Schrijver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid A. Schrijver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid A. Schrijver. The network helps show where Ingrid A. Schrijver may publish in the future.

Co-authorship network

The 20 scholars most cited alongside Ingrid A. Schrijver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingrid A. Schrijver Line = papers co-authored together Ingrid A. Schrijver links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 2001111
2 200123
3 200113
4 2000237
5 200078
6
Bacterial peptidoglycan in rheumatoid arthritis and multiple sclerosis
20001
7 200020
8 199932
9 1998127

About Ingrid A. Schrijver

Ingrid A. Schrijver is a scholar working on Microbiology, Immunology and Rheumatology, having authored 9 papers that have together received 642 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Immunotherapy and Immune Responses (3 papers), Antimicrobial Peptides and Activities (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Probiotics and Fermented Foods (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Immunodeficiency and Autoimmune Disorders (1 paper) and Musculoskeletal synovial abnormalities and treatments (1 paper). The work is most often cited by research in Immunology (333 citations), Microbiology (81 citations) and Biological Psychiatry (22 citations). Ingrid A. Schrijver has collaborated with scholars based in Netherlands. Frequent co-authors include M. P. Hazenberg, Paul P. Tak, Ferdinand C. Breedveld, Ineke M. van der Heijden, Bert Wilbrink, Ilja Tchetverikov, Leo M. Schouls, Marie‐José Melief, Ben J. Appelmelk and Petra van Langevelde. Their work appears in journals such as Brain, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026